Ajanta Pharma Archives - Express Pharma

Ajanta Pharma Q2 net profit dips 7 to Rs 116 crore

KEY NOTE ADDRESS: Molecule to market

Ajanta Pharma’s total comprehensive income dips by 23% in Q1 FY 2018

Ajanta Pharma receives US FDA approval for migraine drug

Ajanta Pharma posts Q4 and FY 2016 results

Ajanta Pharma gets US FDA nod for migraine pain relief drug

Ajanta Pharma Q3 net up 20 per cent at Rs 111.3 crore

Ajanta Pharma launches montelukast IR and montelukast chewable tablets

Ajanta Pharma posts Rs 438 crore consolidated revenue in Q2 of FY 2015-16

Ajanta Pharma bags recognition from Fortune India